​

Theriva Biologics (TOVX) Revenue & Revenue Breakdown

OverviewFinancialsChartTranscripts

Theriva Biologics Revenue Highlights

00

Theriva Biologics Revenue by Period

Theriva Biologics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--100.00%
2010-12-31$3.16M2969.69%
2009-12-31$103.09K100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-12-31--100.00%
2002-12-31$10.00K-98.86%
2001-12-31$874.10K72.55%
2000-12-31$506.57K26.84%
1999-12-31$399.38K-0.16%
1998-12-31$400.00K-20.00%
1997-12-31$500.00K-
1996-12-31$500.00K400.00%
1995-12-31$100.00K-
1994-12-31$100.00K-
1993-12-31$100.00K-

Theriva Biologics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Theriva Biologics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$758.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31--100.00%
2011-12-31$-972.12K-431.31%
2011-09-30$293.42K-17.48%
2011-06-30$355.56K10.03%
2011-03-31$323.14K-47.85%
2010-12-31$619.69K113.76%
2010-09-30$289.90K-86.79%
2010-06-30$2.19M3555.77%
2010-03-31$60.04K15.45%
2009-12-31$52.00K1.80%
2009-09-30$51.09K100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30--

Theriva Biologics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Theriva Biologics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRKRMarker Therapeutics$3.31M$1.93M
PRAXPraxis Precision Medicines$2.45M$302.00K
SABSSAB Biotherapeutics$2.24M$263.14K
LUMOLumos Pharma$2.05M$488.00K
AVTXAvalo Therapeutics$1.41M-
VCNXVaccinex$570.00K$52.00K
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
XCURExicure--
TOVXTheriva Biologics--
LSTALisata Therapeutics--
REVBRevelation Biosciences--
GOVXGeoVax Labs-$300.68K
PMVPPMV Pharmaceuticals--
VRPXVirpax Pharmaceuticals--
PTIXProtagenic Therapeutics-$50.29K
SLRXSalarius Pharmaceuticals--

TOVX Revenue FAQ

What is Theriva Biologics’s yearly revenue?

Theriva Biologics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TOVX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Theriva Biologics’s quarterly revenue?

Theriva Biologics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $758K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). TOVX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Theriva Biologics’s revenue growth rate?

Theriva Biologics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.